Peregrine Capital Management’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-217,403
Closed -$29.7M 333
2018
Q2
$29.7M Sell
217,403
-24,203
-10% -$2.2M 0.74% 33
2018
Q1
$19M Sell
241,606
-40,258
-14% -$2.97M 0.47% 81
2017
Q4
$19.2M Sell
281,864
-48,957
-15% -$2.54M 0.45% 81
2017
Q3
$13.3M Buy
+330,821
New +$12.8M 0.32% 129

Peregrine Capital Management's FMI Position: Q3 2018 in Review

Peregrine Capital Management sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 217,403 shares — an estimated $29.7M sold.

Peregrine Capital Management first reported a position in FMI in Q3 2017 and held it in 4 quarters. The position peaked at $29.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • Peregrine Capital Management reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
  • Peregrine Capital Management sold 217,403 Foundation Medicine, Inc. shares in Q3 2018, an estimated $29.7M.
  • Peregrine Capital Management first reported a position in Foundation Medicine, Inc. in Q3 2017 and held it in 4 quarters.
  • Peregrine Capital Management's Foundation Medicine, Inc. position peaked at $29.7M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Peregrine Capital Management's 13F filing for Q3 2018, filed 18 Oct 2018.